Physical Activity and Medications: Important Considerations for Fitness and Exercise Professionals

A. Fuite, Veronica Jamnik


The development of chronic disease conditions (CDCs) is linked to poor lifestyle choices and, consequently, the management of disease is shifting toward therapeutic lifestyle intervention concurrent to drug therapy. Fitness professionals are now commonly working with clients who have various chronic diseases and who may be managing both their disease and associated co-morbidities with pharmacotherapy. Common medications such as non-steroid anti-inflammatory drugs, HMG-CoA reductase inhibitors/statins, ACE inhibitors, calcium channel blockers, ?-blockers, and oral hypoglycaemic agents may alter their cardiorespiratory, musculoskeletal or metabolic responses to physical activity (PA). There are many paradoxical and even adverse side effects when PA and medications are combined and these alterations need to be taken into account by qualified exercise professionals (QEP) when working with clients with CDCs. This paper examines some common drug-exercise interactions and recommends appropriate precautions for monitoring the PA programs of clients taking medications.


Chronic Disease; Lifestyle Intervention; Fitness; Exercise; Drug Interactions

Copyright (c)

ISSN: 19206216